Funding for this research was provided by:
Received: 8 April 2022
Accepted: 15 June 2022
First Online: 27 June 2022
: This study was conducted in accordance with Good Clinical Practice guidelines and guiding principles of the Declaration of Helsinki, and was approved by the local Institutional Review Boards at Rush University Medical Center (No. 21040601) and Comité de Ética en Investigación Hospital Civil Fray Antonio Alcalde (No. HCG/CEI-0753/21). Written consent was waived by ethic committees at both hospitals.
: Not applicable.
: JL discloses research funding from Fisher & Paykel Healthcare Ltd, Aerogen Ltd, and Rice Foundation, and speaker fees from AARC, Aerogen Ltd, Heyer Ltd, and Fisher & Paykel Healthcare Ltd. OR discloses a research grant from Hamilton Medical and speaker fees from Hamilton Medical, Ambu, Fisher & Paykel Ltd and Aerogen Ltd, and non-financial research support from Timpel and Masimo Corporation. DLV discloses research funding from Teleflex Medical, Inc. and Rice Foundation, and speaker fees from Theravance Biopharma. RK discloses research funding from the American Association of Respiratory Care. All other authors have no conflict of interest to disclose.